Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment
Open Access
- 1 March 1994
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 23 (3) , 331-346
- https://doi.org/10.1016/s0272-6386(12)80994-2
Abstract
No abstract availableKeywords
This publication has 115 references indexed in Scilit:
- Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic originBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- Mesangial function and glomerular sclerosis in rats after unilateral nephrectomyKidney International, 1982
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- The effect of α1-acid glycoprotein (orosomucoid) on triglyceride metabolism in the nephrotic syndromeBiochemical and Biophysical Research Communications, 1977
- FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATIONThe Lancet, 1974
- Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoproteinBiochemical and Biophysical Research Communications, 1972
- STUDIES ON THE METABOLISM OF PLASMA PROTEINS IN THE NEPHROTIC SYNDROME. II. THE LIPOPROTEINS12Journal of Clinical Investigation, 1958